UFD1 Recognition of Initiator and Proximal Ubiquitin Drives p97-Mediated Substrate Unfolding enhanced by FAF1, FAF2, and UBXD7

⚕️

This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine your body is a bustling city, and inside every cell, there's a massive recycling plant called the Proteasome. Its job is to break down old, damaged, or unwanted proteins so the city can reuse the parts. But before a protein can be recycled, it needs to be tagged with a "trash can" label called Ubiquitin.

However, these tagged proteins are often tangled, folded up tight, or stuck in complex machines. They can't just be shoved into the recycling chute; they need to be unfolded first. This is where the main worker, a molecular machine called p97, comes in. Think of p97 as a powerful winch or a cable puller that grabs the tagged protein and physically pulls it apart, strand by strand, so the recycling plant can eat it.

But p97 is a bit clumsy on its own. It needs a team of helpers (adaptors) to know what to grab and how to pull. This paper focuses on two main helpers: UFD1 and NPL4, and how other specialized tools like FAF1, FAF2, and UBXD7 make the job even faster and more efficient.

Here is the story of what the scientists discovered, explained simply:

1. The "Unfolding" Problem

The first step in recycling is grabbing the very first tag (the "initiator" ubiquitin) and pulling it out. The problem is that this tag is usually folded up like a tightly knotted ball of yarn. It's hard to grab a knot.

The scientists found that the helper UFD1 has a special "grip" (a groove in its structure) that acts like a molecular vice.

The Discovery: They solved a high-resolution crystal structure (like a super-clear 3D photo) showing exactly how UFD1 grabs the tag.
The Analogy: Imagine the ubiquitin tag is a folded origami crane. UFD1 doesn't just grab the outside; it reaches in, forces the crane to unfold, and holds the loose paper ends in a special pocket. This prevents the crane from folding back up. Once it's held open, the main winch (p97) can grab the string and start pulling.

2. The "Double-Handed" Grip

The paper reveals that UFD1 doesn't just hold the unfolded tag; it also holds onto the next tag in the chain (the "proximal" ubiquitin).

The Analogy: Think of it like a climber scaling a rock face. UFD1 uses one hand to hold the rock (the next tag) for stability, while the other hand reaches out to grab the loose rope (the unfolded tag) to keep it from slipping. This two-handed grip ensures the machine doesn't lose its grip on the protein while it's being pulled apart.

3. The Specialized Tools: FAF1, FAF2, and UBXD7

The researchers also looked at three other helpers (adaptors) that make the p97 winch work much faster. They found that while they all do the same job, they use completely different strategies to get there.

Strategy A: The Rigid Scaffold (FAF1 and FAF2)

How it works: These helpers have a long, stiff, rod-like structure (a helix) that acts like a scaffolding pole.
The Analogy: Imagine UFD1 is a flexible rubber band that sometimes flops around and can't reach the right spot. FAF1 and FAF2 are like a rigid metal pole that clips onto the rubber band and holds it perfectly straight, pointing it exactly where the p97 winch needs it. They physically position the "grip" so it's ready to catch the tag immediately.
Key Finding: The position of this pole is critical. If you shorten it or twist it slightly, the machine stops working. It's like a crane operator needing the hook to be exactly 5 feet away from the load.

Strategy B: The Stabilizing Glue (UBXD7)

How it works: UBXD7 doesn't have a stiff pole. Instead, it has a flexible, sticky tail that acts like duct tape or superglue.
The Analogy: When the protein is just starting to be unfolded, the grip is shaky and weak. UBXD7 swoops in and "glues" the grip (UFD1) to the tag chain, holding them together long enough for the winch to get a good pull. It stabilizes a moment that would otherwise fall apart.
Key Finding: It uses a specific "sticky" region to hold the chain in place, ensuring the machine doesn't slip before the heavy lifting begins.

4. Why This Matters

The "Rate-Limiting Step": The hardest part of the whole process is the very first second: getting that first folded tag to open up and stay open. This paper shows exactly how the cell solves that problem.
Medical Implications: The "grip" that UFD1 uses to hold the unfolded tag is a unique pocket that no other human protein has. The scientists suggest this is a perfect target for new drugs.
- The Metaphor: Current drugs that stop p97 are like throwing a wrench into the whole engine; they stop everything, which causes side effects. These new potential drugs would be like jamming just the specific gear that grabs the trash tag. This would stop the recycling of bad proteins (which helps fight cancer) without breaking the rest of the cell's machinery.

Summary

In short, this paper is a detailed blueprint of a molecular recycling crew. They discovered that UFD1 is the master gripper that forces tags to unfold, while FAF1/FAF2 act as rigid scaffolds to hold the gripper in place, and UBXD7 acts as a stabilizer to glue the grip to the chain. Together, they ensure the cell's trash is efficiently pulled apart and recycled, keeping the city of the cell clean and running smoothly.

1. Problem Statement

The AAA-ATPase p97 (also known as VCP or Cdc48) is a critical molecular machine that extracts and unfolds ubiquitinated substrates for proteasomal degradation. This process is mediated by the primary adaptor heterodimer UFD1–NPL4 (UN). While previous cryo-EM studies established that substrate processing begins with the unfolding of the "initiator" ubiquitin (Ub $_{init}$ ) and its capture by NPL4, the specific structural mechanism by which UFD1 recognizes and engages K48-linked ubiquitin chains remained unclear.

Key unresolved questions included:

How does UFD1 achieve high-affinity engagement with K48-chains, given its historically weak affinity for native, folded chains?
What is the structural basis for UFD1's specificity for K48 linkages?
How do accessory adaptors (FAF1, FAF2, UBXD7) enhance the unfolding activity of the p97–UN complex, and do they utilize divergent structural strategies?

2. Methodology

The study employed a multidisciplinary approach combining structural biology, computational modeling, and biochemical assays:

AlphaFold3 (AF3) Structural Prediction: Used to generate initial hypotheses for the interaction between UFD1-UT3 and ubiquitin chains. Crucially, the authors utilized AF3 to model the unfolded state of the initiator ubiquitin (residues 51–76), which guided experimental design.
Chemical Synthesis: To validate AF3 predictions, the authors chemically synthesized a K48-linked di-ubiquitin mimic (K48-Ub2 $_{init}$ ). This mimic featured an isopeptide bond where the C-terminal segment of the initiator ubiquitin (residues 65–76) was linked to Lys48 of the proximal ubiquitin, effectively mimicking the unfolded state required for UFD1 binding.
X-ray Crystallography: Determined the high-resolution (1.31 Å) crystal structure of the human UFD1-UT3 domain in complex with K48-Ub2 $_{init}$ .
Bio-layer Interferometry (BLI): Measured binding affinities ( $K_d$ ) between UFD1-UT3 and various ubiquitin constructs (mono-Ub, folded K48-Ub2, and unfolded K48-Ub2 $_{init}$ ).
In Vitro Unfolding Assays: Utilized fluorescence-based single-turnover assays with mEos3.2 substrates (K48-linked and M1/K48-branched chains) to quantify the unfolding activity of p97–UN complexes containing wild-type or mutant UFD1/adaptors.
Cellular Assays: Conducted Cycloheximide (CHX) chase assays in HEK293T cells to assess protein degradation rates and FACS-based pexophagy assays in HCT116 cells to evaluate FAF2 function.
Mutagenesis: Systematic site-directed mutagenesis of UFD1, FAF1, FAF2, and UBXD7 to validate structural interfaces and functional motifs.

3. Key Contributions and Results

A. Structural Mechanism of UFD1 Recognition

Dual Recognition Model: The 1.31 Å crystal structure revealed that UFD1-UT3 engages the ubiquitin chain via two distinct subdomains:
- Nn subdomain: Binds the proximal ubiquitin (Ub $_{prox}$ ) in a folded state.
- Nc subdomain: Binds the initiator ubiquitin (Ub $_{init}$ ) specifically in an unfolded state.
The "Unfolded" Groove: The Nc subdomain contains a specific groove that accommodates the C-terminal tail of Ub $_{init}$ (residues 68–76). In the native folded state, these residues are buried in an intramolecular $\beta$ -sheet. Upon unfolding, this segment forms an intermolecular $\beta$ -sheet with UFD1-UT3 (residues 185–190).
Hydrophobic Sequestration: The Nc subdomain also sequesters a cluster of hydrophobic residues (Leu67, 69, 71, 73) from the C-terminus of Ub $_{init}$ , preventing spontaneous refolding.
Affinity Switch: BLI assays confirmed that UFD1-UT3 has negligible affinity for folded K48-chains but exhibits high-affinity binding ( $K_d \approx 17.4$ nM) to the unfolded mimic (K48-Ub2 $_{init}$ ). This confirms that UFD1 acts as a "proofreader" that stabilizes the unfolded state, preventing refolding and ensuring processivity.

B. Divergent Strategies of Accessory Adaptors

The study identified that FAF1, FAF2, and UBXD7 enhance p97–UN activity through distinct structural mechanisms, all converging on the UFD1-UT3 module:

FAF1 and FAF2 (The "Scaffold" Strategy):
- These adaptors possess a rigid, extended helix connecting their UAS and UBX domains.
- Within this helix lies a conserved Helical Unfolding Enhancer (HUE) motif (sequence: $Q^{dea}YxxSL^{xa}D$ ).
- Mechanism: The HUE motif binds UFD1-UT3 and the proximal ubiquitin, while the UBX domain binds a specific N-terminal domain (NTD) of the p97 hexamer. This acts as a rigid scaffold, positioning the flexible UFD1-UT3 near the NPL4-tower to facilitate the coordinated unfolding of Ub $_{init}$ .
- Validation: Mutations disrupting the HUE motif or the helix orientation (e.g., helix shortening) abolished enhancement activity. Cellular assays showed these mutants failed to rescue protein degradation or suppress pexophagy.
UBXD7 (The "Stabilizer" Strategy):
- UBXD7 lacks the rigid helix found in FAF1/FAF2 and instead has a flexible linker.
- Mechanism: UBXD7 utilizes its UAS domain and a newly identified pre-UAS region (residues 78–90) to stabilize the transient interaction between UFD1-UT3 and Ub $_{prox}$ .
- Validation: Mutations in the pre-UAS (e.g., R78A) or UAS domain abolished enhancement. Unlike FAF1, UBXD7 requires its UBA domain to tether to distal ubiquitins, positioning the UAS/pre-UAS correctly to capture the proximal chain.
Non-Cooperative Activation: Biochemical assays demonstrated that FAF1 and UBXD7 do not synergize; they compete for the same specific p97-NTD binding site, resulting in a 6:1:1 stoichiometry (p97 hexamer : UN : Adaptor).

4. Significance

Mechanistic Insight: The paper provides the first atomic-level model of how the p97–UN complex initiates substrate unfolding. It resolves the "chicken-and-egg" problem of how a machine unfolds a stable protein by showing that UFD1 specifically recognizes and stabilizes the unfolded state of the initiator ubiquitin, preventing refolding.
Therapeutic Implications: The identification of the Ub $_{init}$ -binding groove in the Nc subdomain of UFD1 offers a novel, highly specific target for drug development. Unlike ATPase inhibitors (e.g., DBeQ) which affect all p97 functions, small molecules targeting this groove could selectively inhibit the Ubiquitin-Proteasome System (UPS) without disrupting other p97 roles (e.g., ERAD, DNA repair), potentially reducing toxicity in cancer therapies.
Adaptor Specificity: The study clarifies how diverse adaptors (FAF1, FAF2, UBXD7) fine-tune p97 activity for specific cellular contexts (e.g., ERAD vs. peroxisomal degradation) by employing different structural strategies (rigid scaffolding vs. transient stabilization) to optimize the initiation step.

In summary, this work defines the structural basis for the initiation of p97-mediated unfolding, highlighting UFD1 as the critical gatekeeper that stabilizes the unfolded initiator ubiquitin, and reveals how accessory adaptors modulate this process through distinct structural mechanisms.